Professor Rudolph Tanzi presents results from testing PBT2 in the “Alzheimer’s in a Dish Model” at the Alzheimer’s Association International Conference in Toronto, Canada.

Abstract from Movement Disorders Conference 2016

Prana is pleased to announce that further analysis of the results of its REACH2HD trial will be featured at the 20th Annual International Movement Disorder Society Congress.

Prana has today announced that is has received a A$6.5 million cash refund under the Australian Government’s R&D Tax Incentive Scheme.

Prana presents unique drug platform at World Orphan Drug Congress

Prana regains compliance with NASDAQ continued listing requirements and continues to work towards FDA submission

Prana Biotechnology AGM Presentation

Prana Biotechnology Limited (ASX:PBT/NASDAQ:PRAN) will host a webcast of its Annual General Meeting on Friday, November 13, 2015, at 9.30am AEDT.

Prana Biotechnology Limited has released its Preliminary Final Report (Appendx 4E) for the 2014-15 financial year.

Prana Biotechnology yesterday announced its financial results for the 12 months to June 30, 2015.